Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Ji Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3179-933X; OpenAlex author ID A5100421176. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
34
Papers, trials and grants by year

2014: 3 papers · 2015: none · 2016: none · 2017: 2 papers · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 2 papers

Papers 11

  1. Deep causal learning for pancreatic cancer segmentation in CT sequences. Co-author DOI 10.1016/j.neunet.2024.106294↗
  2. Integrating plasma protein-centric multi-omics to identify potential therapeutic targets for pancreatic cancer. Last author DOI 10.1186/s12967-024-05363-9↗
  3. Gemcitabine-Loaded Albumin Nanoparticle Exerts An Antitumor Effect on Gemcitabine-Resistant Pancreatic Cancer Cells Induced by MDR1 and MRP1 Overexpression in … Last author DOI 10.3389/fsurg.2022.890412↗
  4. Sodium cantharidinate, a novel anti-pancreatic cancer agent that activates functional p53. Co-author DOI 10.1007/s11427-019-1753-3↗
  5. WD repeat-containing protein 1 maintains β-Catenin activity to promote pancreatic cancer aggressiveness. Co-author DOI 10.1038/s41416-020-0929-0↗
  6. Phellodendrine chloride suppresses proliferation of KRAS mutated pancreatic cancer cells through inhibition of nutrients uptake via macropinocytosis. Co-author DOI 10.1016/j.ejphar.2019.01.060↗
  7. An evaluation study of reported pancreatic adenocarcinoma risk-associated SNPs from genome-wide association studies in Chinese population. Co-author DOI 10.1016/j.pan.2017.09.009↗
  8. Portal vein resection and reconstruction with artificial blood vessels is safe and feasible for pancreatic ductal adenocarcinoma patients with portal vein invo… Co-author DOI 10.18632/oncotarget.20847↗
  9. Magnetic graphene-based nanotheranostic agent for dual-modality mapping guided photothermal therapy in regional lymph nodal metastasis of pancreatic cancer. Co-author DOI 10.1016/j.biomaterials.2014.07.064↗
  10. How to improve the efficacy of endoscopic ultrasound-guided celiac plexus neurolysis in pain management in patients with pancreatic cancer: analysis in a singl… Co-author DOI 10.1097/sle.0000000000000032↗
  11. FOXP3+ lymphocyte density in pancreatic cancer correlates with lymph node metastasis. Co-author DOI 10.1371/journal.pone.0106741↗

Closest collaborators

The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Deliang Fu · 7 shared papers, 2014–2024 · strength 0.69
  2. Jichun Gu · 4 shared papers, 2017–2024 · strength 0.53
  3. Chen Jin · 5 shared papers, 2014–2022 · strength 0.43
  4. Yishen Mao · 2 shared papers, 2020–2024 · strength 0.38
  5. Baian Tao · 2 shared papers, 2022–2024 · strength 0.37
  6. Hengchao Li · 2 shared papers, 2020–2024 · strength 0.31
  7. Shu‐Heng Jiang · 2 shared papers, 2020–2024 · strength 0.31
  8. Yi Guo · 1 shared paper, 2024 · strength 0.28
  9. Chengkang Li · 1 shared paper, 2024 · strength 0.28
  10. Pyone Myat Thu · 2 shared papers, 2019–2021 · strength 0.23
  11. Ping Li · 2 shared papers, 2019–2021 · strength 0.23
  12. Xiaojun Xu · 2 shared papers, 2019–2021 · strength 0.23
  13. Yongjian Jiang · 3 shared papers, 2014–2020 · strength 0.21
  14. Siyu Zhou · 1 shared paper, 2024 · strength 0.21
  15. Lie Yao · 3 shared papers, 2014–2020 · strength 0.21
  16. Di Yang · 3 shared papers, 2014–2020 · strength 0.18
  17. Junyuan Deng · 1 shared paper, 2022 · strength 0.16
  18. Lei Kong · 1 shared paper, 2022 · strength 0.16
  19. Jiali Du · 1 shared paper, 2022 · strength 0.16
  20. Feng Yang · 3 shared papers, 2014–2017 · strength 0.15
  21. Xiaoxiao Liu · 1 shared paper, 2021 · strength 0.14
  22. Peng Yang · 1 shared paper, 2021 · strength 0.14
  23. Xiaohui Liu · 1 shared paper, 2020 · strength 0.10
  24. Pengyuan Yang · 1 shared paper, 2020 · strength 0.10
  25. Zu‐Guo Zheng · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.